C. Qi et al. / Tetrahedron 65 (2009) 1316–1320
1319
Agilent Technologies 1790 GC (with a TC-WAX capillary 25 m col-
umn) instrument. Mass spectra were obtained on a HEWLETT 5890
PACKARD SERIES II GC/MS spectrometer with a PEG-25M column.
Element analyses were obtained with a Flash EA 1112 Element An-
alyzer in the Institute of Chemistry, Chinese Academy of Sciences.
2.75 (s, 3H). 13C NMR (75 MHz, CDCl3)
d
158.5, 147.7, 144.1, 141.8,
133.3, 131.6, 130.3, 130.0, 129.5, 127.7, 127.3, 126.7, 123.8, 123.4,
122.0, 19.0. GC–MS m/z (% relative intensity): 299 (Mþ, 21), 297
(Mþ, 23), 218 (100), 203 (9), 189 (7), 109 (23). IR (KBr): 3062, 2961,
2926, 1601, 1589, 1557, 1500, 1097, 1042, 824 cmꢁ1. TLC Rf¼0.35
(silica, CH2Cl2). Anal. Calcd for C16H12BrN: C, 64.45; H, 4.06; N, 4.70.
Found: C, 64.64; H, 4.15; N, 4.68.
4.2. Typical experimental procedure for the formation of
quinoline 2a (Table 1, entry 16)
4.3.5. 6-Bromo-2-(20,50-dibromophenyl)-4-methylquinoline (2e)
Yellow solid, mp 162.0–162.5 ꢀC (recrystallization from a mix-
ture of solvents of n-hexane, CH2Cl2, and THF). 1H NMR (300 MHz,
In a thick-walled Pyrex screw-cap tube (10 mL) equipped with
a
magnetic stirring bar were placed o-chloroacetophenone
(309.0 mg, 2.0 mmol), urea (420.0 mg, 7.0 mmol), and toluene
(0.5 mL). The tube was capped and the mixture was stirred at 150 ꢀC
for 60 h. After the reaction mixture was cooled to room tempera-
ture, CH2Cl2 (10 mL) was added, and the insoluble materials were
filtrated off. The filtrate was then subjected to GC and GC–MS
analyses. Removal of solvent and volatiles under reduced pressure
afforded a viscous residue, which was dissolved in CDCl3 (2.0 mL),
and ferrocene (22.9 mg) was added as internal material for 1H NMR.
Compound 2a was isolated in 189.2 mg (0.748 mmol, 75%) as
colorless solid by column chromatography (silica gel, eluted with
petroleum ether/ethyl acetate¼100:0–100:20). Recrystallization of
2a in CH2Cl2 and n-hexane gave the suitable crystals for X-ray dif-
fraction analysis. 1H NMR analysis of the reaction mixture disclosed
that 2a was formed in 81% yield.
CDCl3)
158.4, 148.5, 144.6, 140.2, 135.7, 132.6, 132.4, 131.0, 130.3, 126.0,
d
8.34–7.46 (m, 7H), 2.74 (s, 3H). 13C NMR (75 MHz, CDCl3)
d
125.3, 123.8, 123.4, 123.3, 122.5, 18.9. GC–MS m/z (% relative in-
tensity): 459 (Mþ, 11), 457 (Mþ, 36), 455 (Mþ, 34), 453 (Mþ, 12), 376
(100), 297 (27), 216 (44), 189 (54), 108 (37). IR (KBr): 2954, 2922,
1600, 1578, 1552, 1493, 1092, 1031, 878 cmꢁ1. TLC Rf¼0.23 (silica,
CH2Cl2). Anal. Calcd for C16H10Br3N: C, 42.15; H, 2.21; N, 3.07.
Found: C, 42.27; H, 2.34; N, 2.99.
4.3.6. 5-(3-Bromo-thiophen-2-yl)-7-methyl-thieno[3,2-b]-
pyridine (2f)
Orange solid, mp 82.0–83.5 ꢀC (recrystallization from n-hexane
and CH2Cl2). 1H NMR (300 MHz, CDCl3)
d 7.99 (s, 1H), 7.74 (d, 1H,
J¼5.5 Hz), 7.60 (d, 1H, J¼5.5 Hz), 7.36 (d, 1H, J¼5.5 Hz), 7.08 (d, 1H,
J¼5.5 Hz), 2.66 (s, 3H). 13C NMR (75 MHz, CDCl3)
d 156.0, 149.6,
4.3. Characterization data for all products
141.8 (2C), 139.2, 132.4, 130.5, 127.2, 125.8, 117.6, 107.8, 20.5. GC–MS
m/z (% relative intensity): 311 (Mþ, 100), 309 (Mþ, 92), 308 (99), 230
(85), 215 (21), 186 (31), 115 (40). IR (KBr): 3048, 2977, 2910, 1564,
1518, 1443, 1365, 708 cmꢁ1. TLC Rf¼0.40 (silica, CH2Cl2). Anal. Calcd
for C12H8BrNS2: C, 46.60; H, 2.59; N, 4.53. Found: C, 46.37; H, 2.83;
N, 4.57.
4.3.1. 2-(20-Chlorophenyl)-4-methylquinoline (2a)
Colorless solid, mp 87.0–87.5 ꢀC (recrystallization from n-hex-
ane and CH2Cl2). 1H NMR (300 MHz, CDCl3)
d
8.18–7.35 (m, 9H),
2.75 (s, 3H). 13C NMR (75 MHz, CDCl3)
d 157.2, 147.9, 143.7, 139.8,
132.3,131.6,130.3,130.0,129.7,129.3,127.2,127.1,126.5,123.7,123.3,
18.9. GC–MS m/z (% relative intensity): 255 (Mþ, 19), 253 (Mþ, 62),
238 (19), 218 (100), 203 (7), 189 (7), 109 (22). IR (KBr): 3058, 2947,
2918, 1602, 1569, 1550, 1507, 1349, 1044, 754 cmꢁ1. TLC Rf¼0.50
(silica, CH2Cl2). Anal. Calcd for C16H12ClN: C, 75.74; H, 4.77; N, 5.52.
Found: C, 75.37; H, 4.85; N, 5.57.
4.3.7. 4-Methyl-2-phenylquinoline (2g)10
Colorless solid (recrystallization with n-hexane and CH2Cl2). 1H
NMR (300 MHz, CDCl3)
(75 MHz, CDCl3) 157.1,148.3,144.9,139.9,130.4,129.4,129.3,128.9,
d
8.18–7.42 (m, 10H), 2.71 (s, 3H). 13C NMR
d
127.6,127.4,126.1,123.7,119.9,19.1. GC–MS m/z (% relative intensity):
219 (Mþ, 100), 204 (70), 189 (6), 174 (24), 132 (22), 108 (19).
4.3.2. 7-Chloro-2-(20,40-dichlorophenyl)-4-methylquinoline (2b)
White solid, mp 181.0–183.0 ꢀC (recrystallization from a mixture
of solvents of n-hexane, CH2Cl2, and THF). 1H NMR (300 MHz,
Acknowledgements
CDCl3)
157.1, 148.6, 144.5, 137.8, 135.6, 135.4, 133.2, 132.6, 130.0, 129.1,
d
8.16–7.37 (m, 7H), 2.74 (s, 3H). 13C NMR (75 MHz, CDCl3)
This project (20573061) was supported by National Natural
Science Foundation of China.
d
127.8, 127.6, 125.8, 125.2, 123.4, 18.9. GC–MS m/z (% relative in-
tensity): 327 (Mþ, 3), 325 (Mþ, 22), 323 (Mþ, 68), 321 (Mþ, 67), 286
(100), 251 (40), 216 (31), 189 (10), 108 (30). IR (KBr): 3062, 2961,
2926, 1601, 1557, 1542, 1500, 1097, 912, 824 cmꢁ1. TLC Rf¼0.35
(silica, CH2Cl2). Anal. Calcd for C16H10Cl3N: C, 59.57; H, 3.12; N, 4.34.
Found: C, 59.31; H, 3.18; N, 4.25.
Supplementary data
Copies of 1H, 13C NMR and MS charts for all products and the full
X-ray structural details for 2a are concluded in Supplementary data.
Supplementary data associated with this article can be found in the
4.3.3. 6-Chloro-2-(20,50-dichlorophenyl)-4-methylquinoline (2c)
White solid, mp 188.0–188.5 ꢀC (recrystallization from a mix-
ture of solvents of n-hexane, CH2Cl2, and THF). 1H NMR (300 MHz,
References and notes
CDCl3)
156.1, 146.3, 143.7, 140.7, 133.2, 132.8, 131.9, 131.6, 131.3, 130.7,
d
8.11–7.32 (m, 7H), 2.73 (s, 3H). 13C NMR (75 MHz, CDCl3)
1. Selected reviews on the synthesis and application of N-heterocyclic com-
pounds, see: (a) Bergstrom, F. W. Chem. Rev. 1944, 35, 77–277; (b) Shawali, A. S.
Chem. Rev. 1993, 93, 2731–2777; (c) Nefzi, A.; Ostresh, J. M.; Houghten, R. A.
Chem. Rev. 1997, 97, 449–472; (d) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104,
2285–2309; (e) Bur, S. K.; Padwa, A. Chem. Rev. 2004, 104, 2401–2432; (f) Ku¨ hl,
O. Coord. Chem. Rev. 2004, 248, 411–427; (g) Watson, I. D. G.; Yu, L.; Yudin, A. K.
Acc. Chem. Res. 2006, 39, 194–206.
2. Selected reports, see: (a) Giardina, G. A. M.; Sarau, H. M.; Farina, C.; Medhurst,
A. D.; Grugni, M.; Raveglia, L. F.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.;
Vecchietti, V.; Hay, D. W. P. J. Med. Chem. 1997, 40, 1794–1807; (b) Nayyar, A.;
Monga, V.; Malde, A.; Coutinho, E.; Jain, R. Bioorg. Med. Chem. 2007, 15, 626–
640; (c) Ilovich, O.; Jacobson, O.; Aviv, Y.; Litchi, A.; Chisin, R.; Mishani, E. Bioorg.
Med. Chem. 2008, 16, 4242–4251.
d
130.6, 130.0, 128.1, 123.8, 122.9, 18.9. GC–MS m/z (% relative in-
tensity): 327 (Mþ, 4), 325 (Mþ, 23), 323 (Mþ, 73), 321 (Mþ, 67), 286
(100), 251 (36), 216 (33), 189 (9), 107 (25). IR (KBr): 3074, 2957,
2923, 1598, 1542, 1490, 1096, 1041, 803 cmꢁ1. TLC Rf¼0.36 (silica,
CH2Cl2). Anal. Calcd for C16H10Cl3N: C, 59.57; H, 3.12; N, 4.34.
Found: C, 59.53; H, 3.18; N, 4.23.
4.3.4. 2-(20-Bromophenyl)-4-methylquinoline (2d)
Pale yellow solid, mp 85.0–86.0 ꢀC (recrystallization from n-
3. (a) Michael, J. P. Nat. Prod. Rep. 2005, 22, 627–646; (b) Michael, J. P. Nat. Prod.
Rep. 2007, 24, 223–246; (c) Michael, J. P. Nat. Prod. Rep. 2008, 25, 166–187.
hexane and CH2Cl2). 1H NMR (300 MHz, CDCl3)
d 8.20–7.24 (m, 9H),